BN Business News
Add your company to Business Communicator →

Business · 22/02/2024Updated: 10/17/2026 · 1 min read

FDA Releases Final Guidance on Assessing COVID-19 Symptoms in Clinical Trials

Summary

The FDA is releasing a final guidance to help sponsors and investigators measure and analyze COVID-19-related symptoms in clinical trials for COVID-19 prevention or treatment, even though the public health emergency has ended.

Original source language: Federal Register — Food and Drug AdministrationOpen original release →

Explore insights

Business insights →